Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/62320
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKawle, Pravin R-
dc.date.accessioned2023-07-20T09:13:42Z-
dc.date.available2023-07-20T09:13:42Z-
dc.date.issued2023-07-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/62320-
dc.description691-695en_US
dc.description.abstractA new series of symmetric acridin-9-yl-bis-benzothiazol-2-yl-amines have been synthesized in good to excellent yields by intra-molecular cyclization of 1-acridin-9-yl-1-benzothiazol-2-yl-3-aryl thiourea and screened for their in vitro antitubercular activity against Mycobacterium tuberculosis by BACTEC radiometric method. The synthesis of new analogues bearing an acridine-linked chloro-substituted benzothiazole has demonstrated enhanced antituberculosis activity.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR,Indiaen_US
dc.sourceIJC Vol.62(07) [July 2023]en_US
dc.subjectTuberculosisen_US
dc.subjectAcridineen_US
dc.subjectBenzothiazoleen_US
dc.titleSynthesis and antituberculosis action of symmetric acridin-9-yl-bisbenzothiazol- 2-yl-aminesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v62i7.430en_US
Appears in Collections:IJC Vol.62(07) [July 2023]

Files in This Item:
File Description SizeFormat 
IJC 62 (07) 691-695.pdf799.6 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.